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Intra-abdominal aortic graft infection: Complete
or partial graft preservation in patients at very high
risk
Keith D. Calligaro, MD,a Frank J. Veith, MD,b John G. Yuan, MD,b Nicholas J. Gargiulo, MD,b and
Matthew J. Dougherty, MD,a Philadelphia, Pa; and New York, NY
Background: Total graft excision with in situ or extra-anatomic revascularization is considered mandatory to treat
infection involving the body of aortic grafts. We present a series of nine patients with this complication and such severe
comorbid medical illnesses or markedly hostile abdomens that traditional treatments were precluded. In these patients
selective complete or partial graft preservation was used.
Methods: Over the past 20 years we have treated nine infected infrarenal aortic prosthetic grafts with complete or partial
graft preservation, because excision of the graft body was not feasible. In all nine patients infection of the main body of
the aortic graft was documented at computed tomography or surgery. Essential adjuncts included percutaneous or
operative drain placement into retroperitoneal abscess cavities and along the graft, with instillation of antibiotics three
times daily, repeated debridement of infected groin wounds, and intravenous antibiotic therapy for at least 6 weeks.
Results: One patient with purulent groin drainage treated with complete graft preservation died of sepsis. One patient
with groin infection treated with complete graft preservation initially did well, but ultimately required total graft excision
5 months later, after clinical improvement. In four patients complete graft preservation was successful; two patients
required excision of an occluded infected limb of the graft; and one patient underwent subtotal graft excision, leaving a
graft remnant on the aorta, and axillopopliteal bypass. In summary, seven of nine patients survived hospitalization after
complete or partial graft preservation; amputation was avoided in all but one patient; and no recurrent infection
developed over mean follow-up of 7.6 years (range, 2-15 years).
Conclusions: Although contrary to conventional concepts, partial or complete graft preservation combined with aggressive
drainage and groin wound debridement is an acceptable option for treatment of infection involving an entire aortic graft
in selected patients with prohibitive risks for total graft excision. This treatment may be compatible with long-term
survival and protracted absence of signs or symptoms of infection. (J Vasc Surg 2003;38:1199-205.)
Although there are several reports of successful nonex-
cisional treatment of peripheral prosthetic graft infections,
most authorities agree that when intracavitary or retroper-
itoneal aortic graft infection develops, total removal of the
prosthesis is mandatory.1-5 However, traditional manage-
ment requiring total graft excision and extra-anatomic re-
construction is associated with high morbidity, mortality,
and rate of limb loss.3-7 Moreover, the conventional graft
excisional approach is clearly not feasible in some patients
with severe comorbid medical illnesses or extremely hostile
abdomens. Although complete or partial graft preservation
of infected aortic grafts has been reported, these were
individual case reports or larger series applied uniformly to
all patients, and the strategy has not received much recent
attention or confirmation of success.8-10 We describe the
clinical features and long-term outcome in nine patients
with intracavitary aortic graft infections and advanced co-
morbid conditions that precluded total graft removal.
PATIENTS AND METHODS
Between January 1, 1982, and December 31, 2002, the
vascular surgical services at Montefiore Medical Center in
New York and Pennsylvania Hospital in Philadelphia
treated infected aortic prosthetic grafts in 70 patients.
These patients were identified with computerized vascular
registries maintained at both institutions. Infection in-
volved an intracavitary or retroperitoneal portion of the
graft, with or without extracavitary involvement, in 36
patients, whereas infection was confined to the groin in the
other 34 patients. Management and outcome in the 34
patients with infection confined to the groin are detailed
elsewhere.1,2 In 27 of the 36 patients with intracavitary
infections, total graft excision was performed, and complete
or partial graft preservation was performed in nine patients
because it was deemed that medical comorbid illnesses or
surgical contraindications (hostile abdomen) would make
total graft excision prohibitively difficult. The records of
these nine patients were retrospectively reviewed, with par-
ticular emphasis on clinical presentation, diagnosis, micro-
biologic features, operative management, and long-term
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outcome. Late follow-up was obtained with office visit or
telephone interview.
The characteristics of the nine patients with intracavi-
tary or retroperitoneal infection of an aortic graft treated
with partial or complete graft preservation are shown in
Table I. Seven patients were men, and two patients were
women; mean age was 69 years (range, 59-73 years). All
patients had known coronary artery disease and previous
myocardial infarction. Two of eight patients had an acute
myocardial infarction within 3 months of onset of graft
infection. In addition, five patients had severe chronic
obstructive pulmonary disease; six patients had diabetes
mellitus; and five patients had chronic renal failure, with
two requiring hemodialysis. Four of the eight patients had
undergone multiple abdominal operations. Two patients
had recently undergone repair of a ruptured abdominal
aortic aneurysm.
Previous aortic surgery had been performed in three
patients for aneurysm repair and in six patients because of
occlusive disease (Table I). Eight patients had Dacron
grafts, and one had a polytetrafluoroethylene graft.
All nine patients were evaluated with computed tomog-
raphy (CT) because of signs or symptoms of graft infection.
In seven patients CT scans demonstrated clear signs of
infection, such as fluid and air, involving the body and at
least one limb of the aortic graft. Two patients without CT
evidence of graft infection underwent sinography to docu-
ment infection of the entire aortic graft. Onset of infection
ranged from 2 days to 180 months (mean, 58 months) after
aortic surgery.
Five patients had groin infection only, without sepsis.
Infection in all five patients was treated with open drainage
and one or more extensive groin wound debridement pro-
cedures. One patient had undergone aortobifemoral bypass
8 years previously, and had an occluded right limb and pus
draining from the right side of the groin. A CT scan
revealed that the right limb of the aortobifemoral graft had
eroded into the cecum. This patient had previously under-
gone total cystectomy with placement of a right lower-
quadrant ureteral loop ileostomy, received pelvic irradia-
tion, had baseline creatinine concentration as high as 2.6
mg/dL, and had underlying coronary artery disease. Treat-
Table I. Characteristics of patients, infection, and graft management
Patient Sex
Age
(y)
Previous graft/
indication
Presentation/
interval (mo) Culture
Operative management of
infected grafts* Outcome
1 M 72 AT/Dacron;
ruptured
aneurysm
Sepsis; 1 Enterobacter
aerogenes,
Proteus
mirabilis,
Escherichia coli
Complete preservation Alive and well, 8.5 y
2 M 71 AT/Dacron;
aneurysm
Sepsis; 180 P mirabilis, E coli Complete preservation Alive and well, 9.5 y
3 M 73 ABF/Dacron;
occlusion
Groin
infection;
23
Pseudomonas
aeruginosa, P
mirabilis
Complete preservation Healed wound; alive
and well, 6.1 y
4 M 59 AUF/Dacron;
occlusion
Groin
infection;
36
MRSA Subtotal excision of AUF
with remnant Dacron
graft left on aorta;
right axillopopliteal
bypass
Required right AKA at
8 y; alive and well, 15
y
5 M 72 ABF/Dacron;
occlusion
Groin
infection;
108
MRSA Subtotal excision of right
limb ABF
Required high right
AKA; died at 10.4 y,
unrelated cause
6 M 72 ABF/Dacron;
ruptured
aneurysm
Groin
infection;
sepsis; 0.5
MRSA, P
mirabilis,
E coli
Complete preservation Died at 3 weeks, of
sepsis and multiple
organ failure
7 M 51 ABF/Dacron;
occlusion
Groin
infection;
60
MRSA, P
mirabilis,
E coli
Complete preservation Recurrent purulent
drainage; required
total graft excision;
alive and well, 5.5 y
8 F 68 ABF/Dacron;
occlusion
Rectal
bleeding,
sepsis; 0.07
E aerogenes,
Clostridia, E coli
Complete preservation Required abdominal
perineal resection;
alive and well, 4 y
9 F 70 ABF/Dacron;
occlusion;
left-to-right
femorofemoral
Groin
infection;
96 10
Staphylococcus
aureus
Excision of distal
occluded right limb of
ABF and
femorofemoral graft
Alive and well, 2 y
ABF, Aortobifemoral graft; AUF, aortounifemoral graft; AT, aortic tube graft; AKA, above-knee amputation; MRSA, methicillin-resistant Staphylococcus
aureus.
*All patients received operative or percutaneous drains along body of aortic graft, at least 6 weeks of appropriate intravenous antibiotic therapy, and repeated
groin debridement as necessary.
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ment consisted of local groin wound debridement and
excision of the distal segment of the right limb of the graft
in the groin.
Two patients had systemic sepsis, without a draining
wound. Pus surrounded the entire body of the graft. In
both patients treatment was complete graft preservation
with abdominal drainage (one open, one percutaneous;
Fig). One of these patients had been operated on to repair
a ruptured abdominal aortic aneurysm with an aortoduo-
denal fistula, after which fascial dehiscence, necrosis of the
abdominal wall with exposed bowel covered by skin grafts,
respiratory failure requiring tracheostomy, and renal and
hepatic failure developed. This was followed by duodenal
breakdown leading to an abscess in contact with the body
of the graft.
One patient had systemic sepsis and pus draining from
a groin wound involving an aortobifemoral graft that had
been placed to repair a ruptured aortoiliac aneurysm. Local
groin wound debridement was performed, with complete
graft preservation.
One patient had ischemic rectal bleeding and sepsis 2
days after aortobifemoral bypass surgery. Abdominal pelvic
resection was required, and pus and stool were found along
both limbs and the body of the aortobifemoral graft. Treat-
ment included complete graft preservation and open drain-
age. A sump drain was inserted through each lower quad-
rant and placed along the corresponding limb of the graft
and along each side of the body of the graft. A dilute
povidone-iodine solution (10 mL of 1% povidone-iodine in
100 mL of normal saline solution) was instilled through
each drain over one-half hour three times a day, and then
the sump drains were connected to intermittent wall suc-
tion. Irrigation was discontinued and the drains were re-
moved when purulent or cloudy fluid was no longer drain-
ing and follow-up CT scans did not show residual abscess or
fluid cavities.
All nine patients underwent percutaneous or operative
placement of drains along the graft, with instillation of 10
mL of 1% povidone-iodine in 100 mL of normal saline
solution, or antibiotics (usually neomycin or cephalospo-
rins), three times daily.
Bacteriologic data were available for all patients (Table
I). Appropriate intravenous antibiotic therapy was admin-
istered for 6 weeks; then oral antibiotic therapy was usually
given for 6 months. CT scans or abdominal ultrasound
scans were obtained at 6-month intervals during follow-up
in all patients who survived hospitalization.
RESULTS
Six patients received graft preservation, and three re-
ceived partial graft preservation (Tables I, II). Of the six
patients with complete preservation, one died and one
initially did well but purulent drainage from the groin
developed 5 months later. At this point the patient was
doing better clinically, and ultimately underwent total graft
excision and bilateral axillo–deep femoral bypass 6 months
after initial onset of infection. The patient continues to
remain clinically well 5 years later, or 51⁄2 years after the
original graft infection. Four patients with successful com-
plete graft preservation remain well, without signs of infec-
tion after long-term follow-up.
Three patients received partial graft preservation. One
patient underwent subtotal graft excision of an aor-
tounifemoral graft, leaving a graft remnant on the aorta,
Abscessogram demonstrates free flow of contrast material through
percutaneous catheter previously placed in cavity (open arrow)
from which pus was obtained. This cavity communicates with
adjacent collection in region of the aortic graft (solid arrow).
Table II. Presentation of graft infection and duration of
survival in eight successfully treated patients
Presentation
No. of
patients
Duration of
symptom-free
survival (y)
Groin infection only 5 6, 15, 10,
5.5,* 9.5 (2)†
Systemic sepsis only 2 8.5, 9.5
Sepsis and rectal bleeding 1 4
*Although this patient did well 5.5 y after initial treatment of infected aortic
graft, complete graft preservation failed 5 mo after initial presentation and
recurrent infection developed. The patient was doing better clinically, and at
that time could tolerate total graft excision and axillofemoral bypass.
†9.5 y after graft placement and 2 y after excision of infection graft from right
groin.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 6 Calligaro et al 1201
and axillopopliteal bypass. This patient required above-
knee amputation 8 years later. One patient had a throm-
bosed right limb of an infected aortobifemoral bypass graft
and absence of any usable outflow vessels, and required
excision of the occluded graft segment and above-knee
amputation. This patient remains well 10 years 5 months
later. One patient had a thrombosed limb of an infected
aortobifemoral graft, and CT scans demonstrated erosion
of the limb of the graft into the cecum. The distal segment
of graft in the groin was excised as far into the retroperito-
neum as possible from the groin, the remaining segment of
the occluded limb was oversewn from the groin, and the
groin wound was extensively debrided. The thrombosed
proximal limb of the graft, including the segment that had
eroded into the cecum, was left in place. CT scans did not
show evidence of fluid or air external to the cecum in the
retroperitoneum or in the peritoneal cavity. The patient is
clinically well 2 years after treatment of the groin graft
infection and 9 years after the original graft placement. The
groin wound remains healed.
All patients except the one who died underwent fol-
low-up CT or duplex scanning of the abdominal aortic
graft, which demonstrated resolution of air or fluid sur-
rounding the graft. One patient had evidence of improving
graft infection, as demonstrated by decreasing inflamma-
tory findings on CT scans, but ultimately underwent total
graft excision because of recurrent purulent drainage from
the groin and increased fluid collections near the stem of
the aortic graft.
In summary, only four of the nine infected intracavitary
aortic grafts were successfully managed with complete graft
preservation. However, complete graft preservation was
attempted in only six patients, and partial graft preservation
in the other three patients. Of the six patients with com-
plete graft preservation, one patient died. One patient with
complete graft preservation ultimately survived because
medical comorbid conditions improved. The three patients
with partial graft excision survived and are doing well,
without recurrent infection, after long-term follow-up, al-
though one required above-knee amputation during hos-
pitalization.
DISCUSSION
Aortic graft infection is one of the most serious com-
plications of vascular reconstruction. However, it occurs
infrequently, with a reported incidence of 1% to 6%.1-5
Although we have reported that selected extracavitary aor-
tic graft infections restricted to the groin and one limb of
the graft may be treated with graft preservation or partial
graft excision,1,2,11 intracavitary or retroperitoneal infec-
tions of an entire aortic graft are traditionally managed with
total graft removal, aortic remnant closure, and extra-
anatomic revascularization. These long, complex, operative
procedures have an associated mortality rate of 15% to 75%
and limb loss rate of 7% to 37%.3-7 Overall results with this
standard approach have improved in recent years, as re-
flected in the commendable lower rates of death and limb
loss.3-7 Collected studies of aortic graft infections treated
with standard technique over the past 20 years indicate that
a significant percentage of patients require repeat opera-
tions because of extra-anatomic bypass complications, in-
cluding graft thrombosis and infection.12-20 These by-
passes exhibit a significant rate of thrombosis when placed
to treat infected aortic grafts, with one series reporting a
primary patency rate of 43% at 3 years and limb loss rate of
33%.12 In addition, these extra-anatomic grafts are subject
to potential risk for infection, causing further limb loss and
death, with reported infection rate as high as 10% to
22%.12-20 Another potential problem associated with tradi-
tional therapy is the significant risk for aortic stump blow-
out, which is almost uniformly fatal, and has been reported
to occur in 5% to 23% of patients after excision of infected
aortic grafts.12-20 The results reported in our small series
are not meant to represent an improvement in mortality or
limb loss rate compared with traditional treatment for all
patients with infected aortic grafts, but possibly improved
treatment in selected patients who are critically ill or have
hostile abdomens and may not tolerate total graft excision.
We are only suggesting that the highly selected patients in
our series might have died if traditional treatment were
carried out.
The high mortality and morbidity and the complica-
tions associated with traditional management have led
many investigators in recent years to seek alternative ap-
proaches. These techniques combine total graft removal
with in situ replacement with autogenous vein or endarter-
ectomized artery, fresh arterial allografts, or other pros-
thetic graft. In situ autogenous aortic reconstruction is safe
and effective, but these procedures are associated with
prolonged operative time and extensive blood loss.21-25
There is risk for continued infection, with graft or anasto-
motic disruption, and the possibility of autogenous graft
failure with stenosis and thrombosis.21-25 Clagett et al23
described an extension of this concept, predominantly us-
ing lower-extremity deep veins to reconstruct a neoaor-
toiliac system. This procedure is a durable option for man-
agement of infected aortic prostheses. However, almost
50% of patents experienced significant perioperative mor-
bidity, including the need for leg fasciotomy because of
acute venous hypertension (12%) and venous thrombosis
(15%). Kieffer et al24 reported that arterial allografts are
another source of in situ conduit replacement. Initial results
have been encouraging, but the long-term durability of
these grafts is unknown. A retroperitoneal in-line aortic
bypass followed by transperitoneal removal of the infected
graft may be another option when total graft excision is
required.25 A retroperitoneal approach is one that we have
previously used and find useful in selected patients, but it
requires aortic clamping and can be a lengthy operation.
We did not consider the retroperitoneal approach or other
strategies to be feasible in the two patients in our series who
had survived ruptured aneurysm repair or in the patient
who had undergone abdominoperineal resection, because
several critical complications developed postoperatively and
we did not believe these patients could tolerate another
major operation or aortic clamping. Bandyk et al26 re-
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ported excellent results with in situ replacement of infected
groin segments of aortofemoral grafts with PTFE grafts
when infection of an aortic graft was due to nonvirulent
organisms, such as coagulase-negative Staphylococcus epi-
dermidis. However, because of the possibility of recurrent
infection, most authorities hesitate to replace an aortic graft
with infection involving the intra-abdominal portion of the
graft with another prosthetic graft placed directly in the
infected field, although minimally contaminated grafts
from aortoenteric fistulas may be an exception. All of these
options still require total graft excision and revasculariza-
tion, which will not be tolerated by patients with severe
comorbid medical problems or patients with extensive pre-
vious abdominal surgery with associated dense adhesions
and extensive scarring, large hernias, or abdominal wall
defects. The one patient in our series in whom a graft cuff
was left on the aorta had extremely dense adhesions in this
area, with bowel segments plastered to the graft cuff, and
we did not believe we could safely perform total graft
excision without causing significant hemorrhage or irre-
versible bowel injury. Clearly, all of these decisions are open
to question, and other surgeons may have successfully
excised the entire aortic graft and performed some form of
lower-extremity revascularization without mortality or
limb loss. We admit that choice of strategy in these patients
emphasizes the limitations of a retrospective report without
clear inclusion or exclusion criteria. Nonetheless, even the
most experienced and skilled vascular surgeon may have a
patient who is too ill to undergo another major operation
or has such a hostile abdomen that total aortic graft excision
is considered impossible or not feasible, and partial or
complete aortic graft preservation may be the only reason-
able alternative.
We believe a reasonable alternative in patients with
infection involving an entire aortic graft and serious medi-
cal or surgical contraindications to total graft removal may
include an initial trial of graft-preserving management with
aggressive adjunctive treatment in carefully selected pa-
tients. This adjunctive treatment includes placement of
drains along the intracavitary segment of the graft, with
instillation of povidone-iodine or antibiotics three times
daily; repeated groin wound debridement, as necessary; and
administration of appropriate intravenous antibiotic ther-
apy for at least 6 weeks. Success with this approach to
treatment of infected aortic grafts with one or more adjunc-
tive treatments has been reported previously in scattered
case reports or in series as large as ours, but most authors
have not emphasized the importance of using this manage-
ment only in patients at very high risk with multiple medical
comorbid conditions or a hostile abdomen.8-10 We are
certainly not recommending that complete or partial graft
preservation be used routinely in patients with infected
intra-abdominal aortic grafts, regardless of surgical risk, as
other authors have suggested.8 Contrary to previous re-
ports, our results in this small series suggest that systemic
sepsis may not be a contraindication to graft preserva-
tion.1,2,11,27 Drainage of retroperitoneal abscesses must be
continued until the abscess cavity is obliterated. Although
graft sterilization may not be theoretically possible, because
antibiotics penetrate prosthetic graft biofilm poorly, a com-
bination of continuous drainage and irrigation, along with
long-term antibiotic therapy, may suppress bacterial activ-
ity and enable eradication of the infection.26,28
Excision of the infected portion of the graft is manda-
tory when frank hemorrhage or infected pseudoaneurysms
occur or usually when the graft is occluded.1,2,5,11,26 If
bleeding or anastomotic dehiscence occurs at the extracavi-
tary regions of an infected aortic graft (ie, at the distal
anastomosis of an aortobifemoral graft), partial graft exci-
sion may be attempted. The body and contralateral limb of
the graft can be preserved, even in patients at good risk. A
thrombosed graft usually mandates excision because orga-
nized thrombus in the graft cannot be sterilized and will
continue to be a focus of infection, and partial graft excision
may be attempted if one limb of the graft is thrombosed
and infected. However, rarely we have used a graft-preserv-
ing strategy in an infected, occluded limb of an aortic graft.
This strategy is controversial if gross pus extends to the
aortic graft bifurcation because the proximal limb of the
thrombosed graft would be oversewn in an infected field
and may be prone to persistent infection ultimately involv-
ing the rest of the graft.
The type of organism (gram-positive vs gram-negative
bacteria) did not influence our decision regarding graft
preservation; rather, our strategy was primarily guided by
associated severe medical comorbid illnesses or hostile ab-
domen, which precluded total aortic graft excision. In our
small series the type of bacteria did not affect the outcome.
We and others have reported that Pseudomonas is associated
with a lower incidence of success of complete graft preser-
vation.11,28 However, in the current series, Pseudomonas
infection in one patient was successfully managed with
complete graft preservation. We caution that Pseudomonas
usually is a contraindication to attempted graft preserva-
tion, but emphasize that the medical illnesses or dense scar
tissue from multiple previous abdominal operations pre-
vented total graft excision in this patient. We speculate that
the nature of the patient-organism (host-bacteria) relation-
ship is as important as the type of bacteria in determining
outcome.
We recognize that the strategy of graft preservation of
infected intracavitary or retroperitoneal aortic grafts is con-
troversial and not to be undertaken lightly. We also recog-
nize that several concerns must be addressed before this
approach is used widely. The number of patients in our
series is small, and a larger series of patients treated in this
manner might be associated with a higher failure rate than
we observed. Another consideration might be the retro-
spective nature of our study and the highly selective way we
used the graft-preserving strategy. Accordingly, we do not
believe this controversial strategy should yet be used in
patients who otherwise could undergo total excision of an
infected aortic graft. Despite our favorable results, we be-
lieve that total graft excision is the best treatment in pa-
tients at reasonably good risk who can be expected to
tolerate a major operation. Nonetheless, in patients with an
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infected aortic graft and severe associated comorbid illness
who will not survive total graft excision, we believe preser-
vation of the infected main body of an aortic graft should be
considered as an option, provided the critical adjunctive
therapies are used.
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DISCUSSION
Dr John Ricotta (Stony Brook, NY). Keith, you may be
surprised that I agree with you. I think you and your group have
reviewed your experience with nonexcisional treatment and this
extends your previous work on your infrainguinal nonexcisional
treatment. I think in this group clearly the risks are a lot higher in
terms of failure often being coincident with mortality.
You’ve shown that in a subgroup of patients at very high risk
for graft removal, graft preservation can be achieved even when the
main body of the graft is involved. I agree with you that this is not
the optimal treatment of these patients, but I have had the oppor-
tunity to treat a couple of cases like this myself, one with necrotiz-
ing pancreatitis 10 days after an aortofemoral bypass and the other
with a colon ischemia and stool spillage. And both of those patients
actually did well over the long term.
That leads me to my first question: Do you think that there is
a difference in the patients that develop this acutely, you might say,
that it’s a contamination process rather than an established infec-
tion process? And if you can wash things out and establish appro-
priate drainage do you think that they may be better off than
somebody who’s got a prolonged infection?
I was a little surprised that you only used 6 weeks of antibiot-
ics. Certainly our experience has been to recommend lifelong
antibiotics for these patients. I wondered whether there were
reasons for that, whether the patients just didn’t want to take the
antibiotics or whether there was a problem with using lifelong
antibiotics or whether you felt that 6 weeks was enough. We have
had some late blowouts in people who have stopped antibiotics
when we’ve done partial graft excision. So I wonder if you could
comment on that.
You listed a number of patients who presented with groin
wound sepsis with involvement of the graft, and at least in the
paper you said this was confirmed by sinogram. Was total graft
infection documented in any other way, ie, an abscess around the
CT scan, or was the sinogram the way that total graft involvement
was identified? And if so, do you recommend that we do sinograms
on all of our patients with graft infection? Do you think somebody
with CT evidence of pus around the body of their aortic graft is
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